Contact
Header_1077x260px_About_Profil.jpg

SURMOUNT-1 demonstrates substantial weight loss with Tirzepatide

β3-adrenoceptor agonist Mirabegron – a candidate anti-obesity drug?

Beer or wine or both – and if both, in which order?

Even moderate overweight increases the risk for cardiovascular disease, recent study says

SUSTAIN 7 - Semaglutide is superior to Dulaglutide

Health claims & the need for scientific evidence in food studies

Alternate –Day Fasting: Any better than other Diets?

New Study about Sugar vs. Calorie-free Sweeteners

TECOS study: No CVD risk or heart failure with sitagliptin in high-risk diabetes patients